ARG1 and neoplasm: Inhibitors like nor-N-hydroxy-L-arginine and aminoguanidin (or 1400W) downregulate ARG-1 and iNOS activity in MDSCs, restore T cell antitumor immunity and reduce tumor progression (176, 268).